Patents by Inventor Ian Irwin

Ian Irwin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8524736
    Abstract: The subject invention provides stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous system.
    Type: Grant
    Filed: February 10, 2012
    Date of Patent: September 3, 2013
    Assignee: Armetheon, Inc.
    Inventors: Ian Irwin, Monica Palme, Cyrus Becker, Pascal J. Druzgala
  • Publication number: 20130040987
    Abstract: The subject invention provides stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous system.
    Type: Application
    Filed: February 10, 2012
    Publication date: February 14, 2013
    Applicant: Armetheon, Inc.
    Inventors: Ian Irwin, Monica Palme, Cyrus Becker, Pascal Druzgala
  • Patent number: 8138204
    Abstract: The subject invention provides stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous system.
    Type: Grant
    Filed: July 16, 2007
    Date of Patent: March 20, 2012
    Assignee: ARYx Therapeutics, Inc.
    Inventors: Ian Irwin, Monica Palme, Cyrus Becker, Pascal Druzgala
  • Publication number: 20080085921
    Abstract: The subject invention provides stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous system.
    Type: Application
    Filed: July 16, 2007
    Publication date: April 10, 2008
    Applicant: ARYx Therapeutics
    Inventors: Ian Irwin, Monica Palme, Cyrus Becker
  • Patent number: 7282509
    Abstract: The subject invention provides stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous system.
    Type: Grant
    Filed: March 23, 2005
    Date of Patent: October 16, 2007
    Assignee: Aryx Therapeutics
    Inventors: Ian Irwin, Monica Palme, Cyrus Becker, Courtney Rubens, Pascal Druzgala
  • Patent number: 7176218
    Abstract: The subject invention provides stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous system.
    Type: Grant
    Filed: January 7, 2005
    Date of Patent: February 13, 2007
    Assignee: ARYx Therapeutics
    Inventors: Ian Irwin, Monica Palme, Cyrus Becker
  • Publication number: 20050197363
    Abstract: The subject invention provides stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous system.
    Type: Application
    Filed: March 23, 2005
    Publication date: September 8, 2005
    Applicant: ARYx Therapeutics
    Inventors: Ian Irwin, Monica Palme, Cyrus Becker
  • Publication number: 20050176757
    Abstract: The subject invention provides stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous system.
    Type: Application
    Filed: January 7, 2005
    Publication date: August 11, 2005
    Applicant: ARYx Therapeutics
    Inventors: Ian Irwin, Monica Palme, Cyrus Becker
  • Patent number: 6545056
    Abstract: Disclosed are methods for treating or preventing inflammatory bowel disease (IBD) using aryl nitrone compounds. Pharmaceutical compositions containing aryl nitrone compounds which are useful for the treatment or prophylaxis of IBD are also disclosed.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: April 8, 2003
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William D. Flitter, William A. Garland, Beverly Greenwood Van-Meerveld, Ian Irwin
  • Patent number: 6486349
    Abstract: Disclosed are methods for treating or preventing inflammatory bowel disease (IBD) using amide and related compounds. Pharmaceutical compositions containing amide compounds which are useful for the treatment or prophylaxis of IBD are also disclosed.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: November 26, 2002
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William D. Flitter, William A. Garland, Beverly Greenwood Van-Meerveld, Ian Irwin
  • Patent number: 6271265
    Abstract: Disclosed are methods for treating or preventing inflammatory bowel disease (IBD) using amide and related compounds. Pharmaceutical compositions containing amide compounds which are useful for the treatment or prophylaxis of IBD are also disclosed.
    Type: Grant
    Filed: May 18, 1999
    Date of Patent: August 7, 2001
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William D. Flitter, William A. Garland, Beverly Greenwood Van-Meerveld, Ian Irwin
  • Patent number: 6258852
    Abstract: Disclosed are methods for treating or preventing inflammatory bowel disease (IBD) using aryl nitrone compounds. Pharmaceutical compositions containing aryl nitrone compounds which are useful for the treatment or prophylaxis of IBD are also disclosed.
    Type: Grant
    Filed: May 8, 2000
    Date of Patent: July 10, 2001
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William D. Flitter, William A. Garland, Beverly Greenwood Van-Meerveld, Ian Irwin
  • Patent number: 6194465
    Abstract: Benzamides are disclosed to be useful for treating and preventing inflammatory bowel disease.
    Type: Grant
    Filed: May 18, 1999
    Date of Patent: February 27, 2001
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William D. Flitter, William A. Garland, Ian Irwin
  • Patent number: 6083989
    Abstract: Disclosed are methods for treating or preventing inflammatory bowel disease (IBD) using aryl nitrone compounds. Pharmaceutical compositions containing aryl nitrone compounds which are useful for the treatment or prophylaxis of IBD are also disclosed.
    Type: Grant
    Filed: May 18, 1999
    Date of Patent: July 4, 2000
    Assignee: Centaur Pharmaceuticals, Inc.
    Inventors: William D. Flitter, William A. Garland, Beverly Greenwood Van-Meerveld, Ian Irwin